Alphamab Oncology
HKEX:9966

Watchlist Manager
Alphamab Oncology Logo
Alphamab Oncology
HKEX:9966
Watchlist
Price: 9.63 HKD 0.1% Market Closed
Market Cap: HK$9.3B

Profitability Summary

Alphamab Oncology's profitability score is 50/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

50/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

50/100
Profitability
Score
50/100
Profitability
Score

Margins

Earnings Waterfall
Alphamab Oncology

Margins Comparison
Alphamab Oncology Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Alphamab Oncology
HKEX:9966
9.2B HKD
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Alphamab Oncology Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Alphamab Oncology
HKEX:9966
9.2B HKD
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
387.5B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
185.5B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
168.8B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
119B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
79.3B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
87B AUD
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
43.2B EUR
Loading...
Loading...
Loading...
Loading...
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
47.2B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Alphamab Oncology

Last Value
3-Years Average
FCF Margin
Conversion Rate